Navigation Links
Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
Date:10/2/2007

BERKELEY, Calif., Oct. 2 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (OTC Bulletin Board: SPDU.OB), announced today that Peter M. Strumph, Chief Executive Officer, will present at the Biotechnology Industry Organization (BIO) Investor Forum on Thursday, October 11, 2007 at 12:30 p.m. Pacific Time at The Palace Hotel in San Francisco, California. Mr. Strumph will provide an overview of Nile and an update on its clinical development programs, including data from Nile's recently completed Phase Ia study for its lead compound, CD-NP.

The presentation will be webcast live and can be accessed by visiting the Investor Relations section at http://www.nilethera.com. The webcast will be archived for ninety days. Additional information regarding the BIO Investor Forum can be accessed at http://investorforum.bio.org.

About Nile Therapeutics, Inc.

Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is developing innovative products for the treatment of cardiovascular disease. Nile is initially focusing its efforts on developing its lead compound, CD-NP, a novel chimeric peptide in Phase I studies for the treatment of heart failure and 2NTX-99, a small molecule, pre-clinical, anti-atherothrombotic agent with nitric oxide (NO) donating properties.

CD-NP, a novel chimeric natriuretic peptide currently in Phase I clinical studies for the treatment of heart failure, is a selective NPRB agonist which, in vivo, has been shown to have potent renal enhancement and cardiac unloading properties but with minimal hypotensive effects compared with competitive products. CD-NP is a rationally-designed synthetic peptide designed to incorporate favorable properties of naturally occurring natriuretic peptides. Data from Nile's recently completed Phase Ia study in healthy volunteers confirmed several pre-clinical findings, includin
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
3. Wisconsin firms to present at Cleantech venture capital event
4. New Sonic Foundry search engine finds words, phrases in video presentations
5. Lone Wisconsin firm to present at InvestMidwest
6. Sonic Foundry creates search engine for 7,000 expert video presentations
7. InvestMidWest calls for business presentations
8. Wicab to present BrainPort at Boston conference
9. Three more Wisconsin firms to present at venture forum
10. Six Wisconsin firms to present at BIO Mid-America VentureForum
11. New Health and Human Services representative for Midwest

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...d . . . , Fuel economy ratings for the new 201...w.fueleconomy.gov web site, which Oak Ridge Natio.... Department of Energy and the U.S. Environmental ...the best fuel economy list are hybrid electrics, l..."This list proves that hybrids have gone mainstrea...
(Date:11/5/2009)...PRNewswire/ -- The endangered black-footed ferrets...is rare carnivore feeds on prairie dogs. The pra... entire population die-offs in towns occur. The U...ted a ferret breeding program and has been releasi...tive habitat. Unfortunately, plague can sweep thr...
(Date:11/5/2009)...re-FirstCall/ -- Imagenetix, Inc. (OTC Bulletin Bo...President and CEO of Imagenetix, will be presentin...onference on Thursday, December 3rd, at 10:30 AM P...LD MICRO ,, LD MICRO is a by-invitation only ne...companies in the micro-cap space. Since 2002, the ...
(Date:11/5/2009)..., November 5, 2009 at 4:30 p.m. Eastern Time ,,...stCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoGe...rted unaudited financial results for the third qua...reviewed the Company,s highlights for the third qu...sults reflect the operations of OncoGenex Technolo...
Breaking Biology Technology:November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...March 11 Haemonetics,Corporation announced today ...d position of Chief Marketing Officer. In this pos...obal marketing of Haemonetics, full,product portfo... President,Donor Division., Brian Concannon, Chie...,architect of our strategic vision to be the globa...
...1 Supelco, a division of,Sigma-Aldrich (Nasdaq: ...line, a family of innovative high-purity liquid ch...e analysis speed and resolving power of,sub-2-micr...scentis Express,HILIC can perform high-speed and h..., "The retention of highly polar compounds such a...
...everage DMetrix,s high-throughput array microscope...dosimetry, TUCSON, Ariz., March 11 DMetrix, Inc....athology systems, the Uniformed,Services Universit...search,Institute (AFRRI), and the Henry M. Jackson...ne (HJF) announced today that they have entered in...
Other Biology Technology:Haemonetics(R) Appoints Peter Allen as Chief Marketing Officer 2Supelco(R) Introduces Ascentis(R) Express HILIC HPLC Columns for High-Speed and High-Efficiency Separations 2DMetrix and the Armed Forces Radiobiology Research Institute Announce Cooperative Research and Development Agreement 2DMetrix and the Armed Forces Radiobiology Research Institute Announce Cooperative Research and Development Agreement 3
(Date:11/4/2009)...s., Oct. 20 Aware, Inc. ...technology and biometrics software, today reported...ptember 30, 2009. ,, Michael Tzannes, Aware,s...ier today, we announced an agreement to sell our D...new fabless semiconductor company being spun out o...
(Date:11/4/2009)...LL Scientists at the University of North Carolina...ity of California, San Francisco have developed an... target diseases for existing drugs. , The resea...res how similar the structures of all known drugs ... known as ligands -- of disease targets within the...
(Date:11/3/2009)...may be the ultimate loner of the ocean, cruising t...f researchers has discovered that the sharks have ...that over tens of thousands of years the white sha...ed themselves into a population genetically distin...sharks are a large, highly mobile species," said S...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Study points to new uses, unexpected side effects of already existing drugs 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4Economic Conditions Signal Long Term Shift in Rx Benefit Approach 57013 1Economic Conditions Signal Long Term Shift in Rx Benefit Approach 57013 2Economic Conditions Signal Long Term Shift in Rx Benefit Approach 57013 3Economic Conditions Signal Long Term Shift in Rx Benefit Approach 57013 4CBC Announces Its Cosmetic Bootcamp University Program is Sold Out for New York 57011 1Elkan Gamzu Ph D Joins Hygeia Therapeutics Board of Directors as Chair 14014 1Elkan Gamzu Ph D Joins Hygeia Therapeutics Board of Directors as Chair 14014 2
...f hearing have found an underlying molecular cause...tion between deafness and the organization of liqu.... , Within the cochlea of the inner ear, sound wav...brations stimulate hair cells, which then trigger ... , Researchers have now learned that mutations in...
...llaboration with colleagues from UC Berkeley and S... has designed a novel pulsed microjet system engin...ut the pain or bruising that deeper penetration in...online today in the Proceedings of the National Ac...free drug delivery systems is driven by a combinat...
...University of Georgia scientists suggests that cur...do little ?if anything ?to reduce rates of antibio...threaten human health. , Dr. Margie Lee, professo...er colleagues have found that chickens raised on a...ristine laboratory conditions have high levels of ...
Other Biology News:Scientists identify molecular cause for one form of deafness 2Researchers design pulsed mircrojet system to deliver protein drugs without pain or bruising 2Study finds antibiotic resistance in poultry even when antibiotics were not used 2Study finds antibiotic resistance in poultry even when antibiotics were not used 3
Chicken Anti-Ras-related C3 botulinum toxin substrate 1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Mouse Anti-HNF-1 Monoclonal Antibody, Unconjugated, Clone 2 from BD Biosciences Pharmingen
Rat Anti-p19ARF Monoclonal Antibody, Unconjugated, Clone 5-C3-1 from Upstate
EDG-1 Western blot control from Exalpha Biologicals, Inc.
Biology Products: